Global Liver Diseases Therapeutics Drugs Market Research Report 2020

Global Liver Diseases Therapeutics Drugs Market Research Report 2020

Table of Contents
1 Liver Diseases Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Liver Diseases Therapeutics Drugs
1.2 Liver Diseases Therapeutics Drugs Segment by Type
1.2.1 Global Liver Diseases Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Injection
1.3 Liver Diseases Therapeutics Drugs Segment by Application
1.3.1 Liver Diseases Therapeutics Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Liver Diseases Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Liver Diseases Therapeutics Drugs Revenue 2015-2026
1.4.2 Global Liver Diseases Therapeutics Drugs Sales 2015-2026
1.4.3 Liver Diseases Therapeutics Drugs Market Size by Region: 2020 Versus 2026
2 Global Liver Diseases Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Liver Diseases Therapeutics Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Liver Diseases Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Liver Diseases Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Liver Diseases Therapeutics Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Liver Diseases Therapeutics Drugs Players (Opinion Leaders)
3 Liver Diseases Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Liver Diseases Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Liver Diseases Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Liver Diseases Therapeutics Drugs Sales by Country
3.3.2 North America Liver Diseases Therapeutics Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Liver Diseases Therapeutics Drugs Sales by Country
3.4.2 Europe Liver Diseases Therapeutics Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liver Diseases Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Liver Diseases Therapeutics Drugs Sales by Country
3.6.2 Latin America Liver Diseases Therapeutics Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Liver Diseases Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Liver Diseases Therapeutics Drugs Price Market Share by Type (2015-2020)
4.4 Global Liver Diseases Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Liver Diseases Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2015-2020)
5.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Liver Diseases Therapeutics Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Liver Diseases Therapeutics Drugs Business
6.1 F. Hoffmann-La Roche
6.1.1 Corporation Information
6.1.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 F. Hoffmann-La Roche Products Offered
6.1.5 F. Hoffmann-La Roche Recent Development
6.2 Gilead Sciences
6.2.1 Gilead Sciences Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.2.2 Gilead Sciences Description, Business Overview and Total Revenue
6.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Gilead Sciences Products Offered
6.2.5 Gilead Sciences Recent Development
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GlaxoSmithKline Products Offered
6.3.5 GlaxoSmithKline Recent Development
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Johnson & Johnson Products Offered
6.4.5 Johnson & Johnson Recent Development
6.5 Merck
6.5.1 Merck Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.5.2 Merck Description, Business Overview and Total Revenue
6.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Merck Products Offered
6.5.5 Merck Recent Development
6.6 Achillion Pharmaceuticals
6.6.1 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.6.2 Achillion Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Achillion Pharmaceuticals Products Offered
6.6.5 Achillion Pharmaceuticals Recent Development
6.7 AbbVie
6.6.1 AbbVie Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.6.2 AbbVie Description, Business Overview and Total Revenue
6.6.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 AbbVie Products Offered
6.7.5 AbbVie Recent Development
6.8 Angion Biomedica
6.8.1 Angion Biomedica Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.8.2 Angion Biomedica Description, Business Overview and Total Revenue
6.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Angion Biomedica Products Offered
6.8.5 Angion Biomedica Recent Development
6.9 Bayer
6.9.1 Bayer Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.9.2 Bayer Description, Business Overview and Total Revenue
6.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Bayer Products Offered
6.9.5 Bayer Recent Development
6.10 LG Life Sciences
6.10.1 LG Life Sciences Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.10.2 LG Life Sciences Description, Business Overview and Total Revenue
6.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 LG Life Sciences Products Offered
6.10.5 LG Life Sciences Recent Development
6.11 Phenex Pharmaceuticals
6.11.1 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.11.2 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Description, Business Overview and Total Revenue
6.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Phenex Pharmaceuticals Products Offered
6.11.5 Phenex Pharmaceuticals Recent Development
6.12 ProMetic Life Sciences
6.12.1 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.12.2 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Description, Business Overview and Total Revenue
6.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 ProMetic Life Sciences Products Offered
6.12.5 ProMetic Life Sciences Recent Development
6.13 Raptor Pharmaceuticals
6.13.1 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.13.2 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Description, Business Overview and Total Revenue
6.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Raptor Pharmaceuticals Products Offered
6.13.5 Raptor Pharmaceuticals Recent Development
6.14 Shenzhen Kangtai Biological Products
6.14.1 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.14.2 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Description, Business Overview and Total Revenue
6.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Shenzhen Kangtai Biological Products Products Offered
6.14.5 Shenzhen Kangtai Biological Products Recent Development
6.15 Verva Pharmaceuticals
6.15.1 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Production Sites and Area Served
6.15.2 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Description, Business Overview and Total Revenue
6.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Verva Pharmaceuticals Products Offered
6.15.5 Verva Pharmaceuticals Recent Development
7 Liver Diseases Therapeutics Drugs Manufacturing Cost Analysis
7.1 Liver Diseases Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
7.4 Liver Diseases Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liver Diseases Therapeutics Drugs Distributors List
8.3 Liver Diseases Therapeutics Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Liver Diseases Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Type (2021-2026)
10.2 Liver Diseases Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Application (2021-2026)
10.3 Liver Diseases Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Region (2021-2026)
10.4 North America Liver Diseases Therapeutics Drugs Estimates and Projections (2021-2026)
10.5 Europe Liver Diseases Therapeutics Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Liver Diseases Therapeutics Drugs Estimates and Projections (2021-2026)
10.7 Latin America Liver Diseases Therapeutics Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Liver Diseases Therapeutics Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Liver Diseases Therapeutics Drugs Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Liver Diseases Therapeutics Drugs Manufacturers Covered in This Study
Table 5. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Liver Diseases Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Liver Diseases Therapeutics Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Liver Diseases Therapeutics Drugs Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Liver Diseases Therapeutics Drugs Sales Sites and Area Served
Table 11. Manufacturers Liver Diseases Therapeutics Drugs Product Types
Table 12. Global Liver Diseases Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Therapeutics Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Liver Diseases Therapeutics Drugs Players
Table 16. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Region (2015-2020)
Table 17. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Liver Diseases Therapeutics Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Liver Diseases Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 21. North America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Liver Diseases Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Liver Diseases Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Type (2015-2020)
Table 41. Global Liver Diseases Therapeutics Drugs Sales Share by Type (2015-2020)
Table 42. Global Liver Diseases Therapeutics Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 44. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Application (2015-2020)
Table 46. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Liver Diseases Therapeutics Drugs Sales Growth Rate by Application (2015-2020)
Table 48. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Corporation Information
Table 49. F. Hoffmann-La Roche Description and Business Overview
Table 50. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. F. Hoffmann-La Roche Main Product
Table 52. F. Hoffmann-La Roche Recent Development
Table 53. Gilead Sciences Liver Diseases Therapeutics Drugs Corporation Information
Table 54. Gilead Sciences Corporation Information
Table 55. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Gilead Sciences Main Product
Table 57. Gilead Sciences Recent Development
Table 58. GlaxoSmithKline Liver Diseases Therapeutics Drugs Corporation Information
Table 59. GlaxoSmithKline Corporation Information
Table 60. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. GlaxoSmithKline Main Product
Table 62. GlaxoSmithKline Recent Development
Table 63. Johnson & Johnson Liver Diseases Therapeutics Drugs Corporation Information
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Johnson & Johnson Main Product
Table 67. Johnson & Johnson Recent Development
Table 68. Merck Liver Diseases Therapeutics Drugs Corporation Information
Table 69. Merck Corporation Information
Table 70. Merck Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Merck Main Product
Table 72. Merck Recent Development
Table 73. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Corporation Information
Table 74. Achillion Pharmaceuticals Corporation Information
Table 75. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Achillion Pharmaceuticals Main Product
Table 77. Achillion Pharmaceuticals Recent Development
Table 78. AbbVie Liver Diseases Therapeutics Drugs Corporation Information
Table 79. AbbVie Corporation Information
Table 80. AbbVie Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AbbVie Main Product
Table 82. AbbVie Recent Development
Table 83. Angion Biomedica Liver Diseases Therapeutics Drugs Corporation Information
Table 84. Angion Biomedica Corporation Information
Table 85. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Angion Biomedica Main Product
Table 87. Angion Biomedica Recent Development
Table 88. Bayer Liver Diseases Therapeutics Drugs Corporation Information
Table 89. Bayer Corporation Information
Table 90. Bayer Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Bayer Main Product
Table 92. Bayer Recent Development
Table 93. LG Life Sciences Liver Diseases Therapeutics Drugs Corporation Information
Table 94. LG Life Sciences Corporation Information
Table 95. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. LG Life Sciences Main Product
Table 97. LG Life Sciences Recent Development
Table 98. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Corporation Information
Table 99. Phenex Pharmaceuticals Corporation Information
Table 100. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Phenex Pharmaceuticals Main Product
Table 102. Phenex Pharmaceuticals Recent Development
Table 103. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Corporation Information
Table 104. ProMetic Life Sciences Corporation Information
Table 105. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. ProMetic Life Sciences Main Product
Table 107. ProMetic Life Sciences Recent Development
Table 108. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Corporation Information
Table 109. Raptor Pharmaceuticals Corporation Information
Table 110. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Raptor Pharmaceuticals Main Product
Table 112. Raptor Pharmaceuticals Recent Development
Table 113. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Corporation Information
Table 114. Shenzhen Kangtai Biological Products Corporation Information
Table 115. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Shenzhen Kangtai Biological Products Main Product
Table 117. Shenzhen Kangtai Biological Products Recent Development
Table 118. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Corporation Information
Table 119. Verva Pharmaceuticals Corporation Information
Table 120. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Verva Pharmaceuticals Main Product
Table 122. Verva Pharmaceuticals Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Liver Diseases Therapeutics Drugs Distributors List
Table 126. Liver Diseases Therapeutics Drugs Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) Forecast by Type (2021-2026)
Table 131. Global Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Liver Diseases Therapeutics Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Liver Diseases Therapeutics Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) Forecast by Application (2021-2026)
Table 135. Global Liver Diseases Therapeutics Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 137. Global Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Liver Diseases Therapeutics Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Liver Diseases Therapeutics Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Liver Diseases Therapeutics Drugs
Figure 2. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Liver Diseases Therapeutics Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Global Liver Diseases Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Liver Diseases Therapeutics Drugs Sales Capacity (K Pcs) (2015-2026)
Figure 11. Global Liver Diseases Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Liver Diseases Therapeutics Drugs Sales Share by Manufacturers in 2020
Figure 13. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Liver Diseases Therapeutics Drugs Revenue in 2019
Figure 15. Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region in 2019
Figure 18. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 20. North America Liver Diseases Therapeutics Drugs Sales Market Share by Country in 2019
Figure 21. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 22. U.S. Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 23. U.S. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 25. Canada Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Country in 2019
Figure 27. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 28. Germany Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 29. Germany Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 31. France Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. U.K. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Italy Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Russia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Region in 2019
Figure 39. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 40. China Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. China Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Japan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. South Korea Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. India Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Australia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Taiwan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Indonesia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Thailand Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Malaysia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Philippines Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Vietnam Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Country in 2019
Figure 63. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 64. Mexico Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Mexico Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Brazil Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Argentina Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 72. Turkey Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Turkey Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Liver Diseases Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. U.A.E Liver Diseases Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Liver Diseases Therapeutics Drugs by Type (2015-2020)
Figure 79. Sales Market Share of Liver Diseases Therapeutics Drugs by Type in 2019
Figure 80. Revenue Share of Liver Diseases Therapeutics Drugs by Type (2015-2020)
Figure 81. Revenue Market Share of Liver Diseases Therapeutics Drugs by Type in 2019
Figure 82. Global Liver Diseases Therapeutics Drugs Sales Growth by Type (2015-2020) (K Pcs)
Figure 83. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 84. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Liver Diseases Therapeutics Drugs by Application (2015-2020)
Figure 86. Global Revenue Share of Liver Diseases Therapeutics Drugs by Application in 2020
Figure 87. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Merck Total Revenue (US$ Million): 2019 Com

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs